María José Herrero

6PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cancer geneticsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 22, 2024
Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's disease.

Inés Moret-Tatay, Pilar Nos, Marisa Iborra

|Mar 29, 2023
Immunoepigenetic Regulation of Inflammatory Bowel Disease: Current Insights into Novel Epigenetic Modulations of the Systemic Immune Response.

Guillermo Bastida, Alejandro Mínguez, Pilar Nos

|Dec 23, 2022
The Genetic Diversity and Dysfunctionality of Catalase Associated with a Worse Outcome in Crohn's Disease.

Marisa Iborra, Inés Moret, Enrique Busó

|Oct 25, 2021
Specific Plasma MicroRNA Signatures in Predicting and Confirming Crohn's Disease Recurrence: Role and Pathogenic Implications.

Inés Moret-Tatay, Elena Cerrillo, David Hervás

|Mar 06, 2021
Multicompartmental Lipopolyplex as Vehicle for Antigens and Genes Delivery in Vaccine Formulations.

Isaías Sanmartín, Luis Sendra, Inés Moret

|Jan 12, 2021
Oxidative Stress in the Pathogenesis of Crohn's Disease and the Interconnection with Immunological Response, Microbiota, External Environmental Factors, and Epigenetics.

Ester Alemany-Cosme, Esteban Sáez-González, Inés Moret

Pageof 1

Frequent Collaborators

3 joint publications

Pilar Nos

2 joint publications

Belén Beltrán

1 joint publications

Ester Alemany-Cosme

1 joint publications

Esteban Sáez-González